Latest Updates
-
Sheetala Ashtami 2026: Significance, Puja Timings, Rituals And The Meaning Behind The Basoda Tradition -
Horoscope for Today March 11, 2026 - Small Choices, Steady Progress -
Vijay Deverakonda, Rashmika Mandanna’s Pradhanam-Mehendi Looks Redefine Celebrity Wedding Fashion This Year -
Lucky Colours For March 2026 According To Zodiac Signs And The Shades You Should Wear -
Randeep Hooda Becomes Father On His Dad’s Birthday, Shares First Baby Photos In Heartwarming Instagram Post -
World Kidney Day 2026: History, Significance And Theme Behind This Global Health Awareness Day -
Who Is Charulatha Remesh? Sanju Samson’s ‘Dear Pondatti’ Post After India’s T20 World Cup Victory Wins Hearts -
Sheetala Saptami 2026: Significance, Vrat Katha And Why Families Eat Cold Food And Avoid Cooking This Day -
Suryakumar Yadav Takes T20 World Cup Trophy To 526 Year Old Adalaj Stepwell -
Horoscope for Today March 10, 2026 - Calm Energy, Steady Progress
Ebola Vaccine Found Safe In Humans Trials
Ebola vaccine has been recently found to be safe in human trials. Read to know.
An Ebola vaccine has been found to be safe and effective for children and adults in a clinical trial, producing an immune response against the deadly disease, say scientists including one of Indian origin. The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide.

It led to urgent action by medical experts across the world to combat this devastating disease; including the setting up of trials of vaccines to stop the disease taking hold. This global commitment to develop a vaccine against the disease suggested eight options, out of a starting pool of 15 candidates, should be evaluated in clinical trials worldwide by the end of 2015.
"An unprecedented Ebola outbreak showed how it is possible for academics, non-governmental organisations, industry and funders to work effectively together very quickly in times of medical crisis," said Sanjeev Krishna, of St George's University of London in the UK. "The results of the trial show how a vaccine could best be used to tackle this terrible disease effectively,"
Krishna said. Considering the persistent replication of the vaccine in children and adolescents, further studies investigating lower doses in this population are warranted. The vaccine contains a non-infectious portion of a gene from the Zaire Ebola virus. In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebola virus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past.

The vaccine was one of two being examined as a 'candidate' option by the World Health Organization (WHO) to identify urgently a vaccine to combat the Ebola virus outbreak in West Africa.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











